StockWatch
·
Biotechnology: Pharmaceutical Preparations
Corporate ActionJul 1, 2026, 01:31 AM

Abivax Shares Temporarily Halted on Euronext Paris

AI Summary

Abivax announced a temporary trading halt of its ordinary shares on Euronext Paris, effective from the market opening on July 1, 2026. This suspension, requested by the company, is related to its previously announced public offering of American Depositary Shares in the United States. The halt is intended to facilitate the confirmation of investor allocations and the announcement of the offering's pricing, with trading expected to resume later today at approximately 3:30 p.m. CEST.

Key Highlights

  • Abivax ordinary shares temporarily halted from trading on Euronext Paris.
  • The trading halt was requested by the company.
  • It is in connection with a previously announced public offering of American Depositary Shares in the US.
  • The halt allows for confirmation of investor allocations and pricing announcement for the offering.
  • Trading is expected to resume today, July 1, 2026, at approximately 3:30 p.m. CEST.